Atlas Trials

Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Clinical trial NCT03566394 · UNKNOWN

Trial details

NCT number
NCT03566394
Sponsor
British Columbia Cancer Agency
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Invasive Breast CancerChemotherapeutic ToxicityMyalgiaArthralgia
Start date
2018-07-02
Primary completion
2019-06-30
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.